A new study reveals how C210, a curcumin derivative, selectively reactivates Epstein–Barr virus to kill cancer cells without infectious risks, paving the way for safer, targeted cancer therapies.
Could a kitchen spice help stop colorectal cancer before it starts? New research shows curcumin selectively attacks the stem-like cells that fuel early tumors, pointing to a promising, low-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback